“…(Ramdass & Koka, 2015) (Tucker, Karamsadkar, Khan, & Pastides, 2010) The efficacy of bone marrow MSCs in the treatment of flexor tendon injury of the equine finger is superior to that of PRP and adipose tissue‐derived MSCs (Romero et al, 2017). Some studies have found that the utilization of MSCs in soft tissue tendon transplantation and reconstruction of the ACL can promote repair and regeneration, which provides the possibility of more physiological and biomechanical ligament reconstruction (Jang, Lim, Jung, Moon, & Wang, 2015; Lim et al, 2004; Park et al, 2018; Van Loon, Scheffer, Genn, Hoogendoorn, & Greve, 2014; Zhang et al, 2017). Moreover, ESCs have almost unlimited developmental potential and self‐renewal ability and can differentiate into almost any kind of organism cell type (Wobus & Boheler, 2005).…”